ABOUT US
Lanier Biotherapeutics advances medical treatments to improve quality of living
We discover and develop antibody treatments to restore and improve better health: seeing, breathing, and believing!
ABOUT US
Lanier Biotherapeutics advances medical treatments to improve quality of living
We discover and develop antibody treatments to restore and improve better health: seeing, breathing, and believing!
OUR PROGRAMS
Advancing lead programs in immune checkpoint inhibitor (ICI) pneumonitis and beyond
The Ideal Treatment for Checkpoint Inhibitor Pneumonitis (CIP)
Protection from pulmonary fibrosis with checkpoint inhibitor amplification
Type 2 Inflammation / Fibrosis
Moderate-to-severe conditions, like asthma, atopic dermatitis, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis and food allergies, with limited response to corticosteroid treatment
The Ideal Treatment for Checkpoint Inhibitor Pneumonitis (CIP)
Type 2 Inflammation / Fibrosis
Retinal
MEET OUR TEAM
We are seasoned visionaries committed to advancing treatment for retinal, dermatological, and respiratory diseases.
Daniel White
Kirby Alton
Martin Simonetti
Christopher McLeod
Investors
Lanier Biotherapeutics is funded by a group of visionary private investors
Connect with us
Headquarters:
Jefferson, GA 30549
Lab:
150 Technology Parkway
Room #130
Peachtree Corners, GA 30092